Dova Pharmaceuticals Inc (NASDAQ:DOVA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark W Hahn Other companies: Soleno Therapeutics, Inc. (Director · Since at least Oct 13, 2025); Verona Pharma plc (Chief Financial Officer · Since at least Jan 1, 2021); ALSP Orchid Acquisition I Corp (Director · Nov 18, 2021 – Nov 18, 2021 · Past); Cempra Inc (EVP and CFO · Feb 2, 2012 – Feb 23, 2017 · Past) | Chief Financial Officer · Jan 31, 2018 – Nov 12, 2019 · Past |
| Alex C. Sapir Other companies: Fulcrum Therapeutics, Inc. (President and Chief Executive Officer · Since at least Jul 1, 2023); PhaseBio Pharmaceuticals Inc (Director · Feb 12, 2020 – May 19, 2023 · Past) | President & CEO, Director · Jun 28, 2017 – Aug 14, 2018 · Past |
| Steven M Goldman Other companies: ConnectOne Bancorp, Inc. (Director · May 3, 2013 – Feb 4, 2014 · Past) | Director · Jun 28, 2017 – Nov 12, 2019 · Past |
| Douglas Blankenship | Chief Financial Officer · Jun 28, 2017 – Jun 28, 2017 · Past |
| Kevin Laliberte | Sr. VP, Product Development · Nov 6, 2017 – Nov 12, 2019 · Past |